A.P. Møller - Mærsk A/S
| On 30 November 2020, A.P. Møller - Mærsk A/S (the Company) announced first phase of a share buy-back program in compliance with the EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). The share buy-back program of up to DKK 10bn is to be executed during a 15-month period beginning 1 December 2020. | |||
| During the first phase of the program running from 1 December 2020 up to 29 April 2021, the Company will buy-back A and B shares for an amount of up to DKK 3.3bn. | |||
| The following transactions have been made under the program in the period 8 March 2021 to 12 March 2021: | |||
| Number of A shares | Average purchase price A shares, DKK | Transaction value, A shares, DKK | |
| Accumulated, last announcement (market and A.P. Møller Holding A/S) | 32,425 | 404,563,969 | |
| 8 March 2021 | 250 | 12,167.7200 | 3,041,930 |
| 9 March 2021 | 240 | 12,666.0833 | 3,039,860 |
| 10 March 2021 | 240 | 12,852.6667 | 3,084,640 |
| 11 March 2021 | 230 | 13,163.0435 | 3,027,500 |
| 12 March 2021 | 230 | 13,112.9565 | 3,015,980 |
| Total 8-12 March 2021 | 1,190 | 15,209,910 | |
| Bought from A.P. Møller Holding A/S* 12 March 2021 | 1,261 | 12,781.4370 | 16,117,392 |
| Accumulated under the program (market and A. P. Møller Holding A/S) | 34,876 | 435,891,271 | |
| Number of B shares | Average purchase price B shares, DKK | Transaction value, B shares, DKK | |
| Accumulated, last announcement (market and A.P. Møller Holding A/S) | 129,660 | 1,744,620,554 | |
| 8 March 2021 | 1,200 | 13,007.6000 | 15,609,120 |
| 9 March 2021 | 1,200 | 13,566.3792 | 16,279,655 |
| 10 March 2021 | 1,200 | 13,748.9958 | 16,498,795 |
| 11 March 2021 | 1,250 | 14,127.2880 | 17,659,110 |
| 12 March 2021 | 1,150 | 14,035.9348 | 16,141,325 |
| Total 8-12 March 2021 | 6,000 | 82,188,005 | |
| Bought from A.P. Møller Holding A/S* 12 March 2021 | 3,841 | 13,698.0008 | 52,614,021 |
| Accumulated under the program (market and A. P. Møller Holding A/S) | 139,501 | 1,879,422,580 | |
| *) According to a separate agreement, A.P. Møller Holding A/S participates on a pro rata basis to the shares purchased in the share buy-back program. | |||
| With the transactions stated above, the Company owns a total of 143,746 A shares and 603,550 B shares as treasury shares, corresponding to 3.73% of the share capital. | |||
| | |||
| Details of each transaction are included as appendix. | |||
| Copenhagen, 15 March 2021 | |||
| Contact persons: | |||
| Head of Investor Relations, Stig Frederiksen, tel. +45 3363 3106 | |||
| Head of Media Relations, Signe Wagner, tel. +45 3363 1901 | |||
Attachments
- Announcement - Transactions in connection with share buy-back program (week 10 2021)
- Daily transactions - week 10
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Allergy and Airways Patient Platform26.10.2025 20:17:14 CET | Press release
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
ARETI International Group26.10.2025 18:41:15 CET | Press release
ARETI International Group, Headed by Igor Makarov, Partners with INEX CLUB to Support the Mayflower Gran Prix Cyprus 2025
Novartis Pharma AG26.10.2025 18:00:00 CET | Press release
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
mediCAD Hectec GmbH26.10.2025 12:45:00 CET | Press release
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
